Dihydromyricetin for Skin Rejuvenation - Quick Reference Sheet
evipedia.ai ← Back

Dihydromyricetin for Skin Rejuvenation

Created on 06/16/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A plant compound from vine tea, applied as a topical serum to rejuvenate skin. It gently loosens the chemical aging tags on skin-cell DNA, fights sugar-driven aging, calms oxidative stress, and evens tone. Early human evidence shows smoother, firmer, less-wrinkled skin after two months, but is preliminary and largely single-source. Benefits appear real but incremental. (Full Review)

Protocol

Form
Leave-on facial serum
Applied to clean skin; favor encapsulated or nano-formulated delivery for penetration
Frequency
Twice daily (AM and PM)
Morning application paired with sunscreen; titrate up from once-daily if sensitive
Pairing
Daily broad-spectrum sunscreen
SPF 30+; ultraviolet exposure re-drives the aging the compound counteracts
Time to effect
Biological skin age
8 weeks
Reduced epidermal methylation age measured after 8 weeks of twice-daily use
Visible aging
4–8 weeks
Roughness and wrinkles measured by 8 weeks; some visible change reported by 4 weeks
Skin tone
Several weeks
Tone-evening effects are gradual; several weeks of consistent use needed before judging

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Known allergy to vine tea, Ampelopsis botanicals, or related flavonoids
  • Actively inflamed or broken skin, until healed
    •
Key Interactions
  • Prescription retinoids (tretinoin, adapalene) or topical corticosteroids
  • OTC exfoliating acids (glycolic acid, salicylic acid) or benzoyl peroxide
  • Oral iron supplements
  • In-office procedures (chemical peels, lasers, microneedling)
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Local skin irritation, redness, or sensitization; uncertainty from mild DNA-demethylation mechanism
    •
  • Speculative: Systemic effects from oral use; pregnancy and lactation safety
    •

Monitoring

Marker Target Why
Skin biological (methylation) age Lower than chronological age Tracks the targeted epigenetic-rejuvenation effect
Serum ferritin (if oral use) 50–150 ng/mL Detects reduced iron status from oral dihydromyricetin's iron-binding
ALT / AST (liver enzymes, if oral use) ALT <25 U/L; AST <25 U/L Confirms liver tolerance with oral supplementation

Cadence: Reassess skin at ~4 and 8 weeks, then every 2–3 months, comparing against baseline photographs; for combined oral use, recheck iron studies and liver enzymes every 6–12 months.

Qualitative Assessment

  • Smoother skin texture and reduced roughness on touch and in photos
  • More even skin tone and fading of dark spots
  • Softened appearance of fine lines and wrinkles
  • Improved skin firmness or "bounce"
  • Absence of irritation, redness, or stinging (a marker of good tolerability)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.